We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...
Fidelity Growth Company Fund's Retail Class (FDGRX) shares gained 7.52%, outpacing the benchmark.Click here to read the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback